down arrow

Henan Lingrui Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001501
CNY
22.07
0.14 (0.64%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Henan Lingrui Pharmaceutical Co., Ltd.
Why is Henan Lingrui Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 11.51% and Operating profit at 19.03% over the last 5 years
2
Negative results in Mar 25
  • INTEREST(HY) At CNY 0.51 MM has Grown at 250.09%
  • INTEREST COVERAGE RATIO(Q) Lowest at 46,461.27
  • DEBT-EQUITY RATIO (HY) Highest at -14.55 %
3
With ROE of 25.60%, it has a attractive valuation with a 4.08 Price to Book Value
  • Over the past year, while the stock has generated a return of -2.17%, its profits have risen by 17.8% ; the PEG ratio of the company is 0.7
  • At the current price, the company has a high dividend yield of 4.1
4
Underperformed the market in the last 1 year
  • Even though the market (China Shanghai Composite) has generated returns of 14.77% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -2.17% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Henan Lingrui Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Henan Lingrui Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Henan Lingrui Pharmaceutical Co., Ltd.
-2.17%
-0.48
23.25%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
11.51%
EBIT Growth (5y)
19.03%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
1.12
Tax Ratio
12.98%
Dividend Payout Ratio
70.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
29.45%
ROE (avg)
18.32%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
4.08
EV to EBIT
15.26
EV to EBITDA
13.74
EV to Capital Employed
4.79
EV to Sales
3.25
PEG Ratio
0.72
Dividend Yield
4.08%
ROCE (Latest)
31.41%
ROE (Latest)
25.60%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 983.25 MM

RAW MATERIAL COST(Y)

Fallen by -2.67% (YoY

NET SALES(Q)

Highest at CNY 1,006.65 MM

-11What is not working for the Company
INTEREST(HY)

At CNY 0.51 MM has Grown at 250.09%

INTEREST COVERAGE RATIO(Q)

Lowest at 46,461.27

DEBT-EQUITY RATIO (HY)

Highest at -14.55 %

Here's what is working for Henan Lingrui Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 983.25 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales
Highest at CNY 1,006.65 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Raw Material Cost
Fallen by -2.67% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Henan Lingrui Pharmaceutical Co., Ltd.
Interest
At CNY 0.51 MM has Grown at 250.09%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio
Lowest at 46,461.27
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio
Highest at -14.55 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."